Levetiracetam Ratiopharm

Levetiracetam, the active ingredient in Levetiracetam Ratiopharm, is an anticonvulsant presented as an oral tablet for oral use. It is used to treat partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide and complies with EU regulatory standards.

Levetiracetam is an anticonvulsant indicated for several seizure types in epilepsy.

- Partial‑onset seizures: reduces the frequency of focal seizures and helps achieve seizure control. - Generalized tonic‑clonic seizures: decreases the occurrence of bilateral convulsive episodes. - Myoclonic seizures: lowers the rate of rapid, brief muscle jerks associated with epilepsy.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or low in energy. - Headache: mild to moderate cranial pain. - Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rapid swelling, difficulty breathing. - Stevens‑Johnson syndrome: serious skin rash with blistering. - Suicidal ideation: thoughts of self‑harm or depression. - Blood dyscrasias: abnormal blood cell counts. - Severe skin rash: extensive erythema or peeling. - Depression or mood changes: significant emotional disturbances.

When prescribing levetiracetam, clinicians should consider several safety factors.

- Renal impairment: adjust dose based on renal function. - Hepatic dysfunction: monitor liver enzymes and consider dose modification. - Psychiatric symptoms: observe for mood changes, depression or suicidal thoughts. - Pregnancy: risk unknown; use only if benefits outweigh potential risks. - Concomitant CNS depressants: may increase sedation or dizziness. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: induces metabolism, lowering levetiracetam levels. - Phenobarbital: increases clearance, reducing therapeutic effect. - Phenytoin: accelerates metabolism, potentially leading to seizure breakthrough.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Opioids: combined use can increase sedation. - Antidepressants: possible additive effects on mood or cognition.